|

Conventional anti-dementia treatment group Clinical Trials

2 actively recruiting trials

▲ +1 trial since May 2026

Pipeline

Phase 4: 1

Top Sponsors

  • First Affiliated Hospital of Wenzhou Medical University1
  • Cuibai Wei，Clinical Professor1

Indications

  • Alzheimer's Disease2
  • MCI-AD, Early Stage Alzheimer's Disease1
  • Functional Magnetic Resonance Imaging1
  • Lecanemab1
  • Alzheimer's Disease1

Other2 trials

Evaluating the Efficacy and Safety of Lecanemab in Alzheimer's Disease Through Multi-omics Approachs
Phase 4
The Clinical Study of Synaptic Plasticity-based Lencanumab for the Treatment of Early Alzheimer's Disease

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.